Table 1. Timeline of interventions and outcomes.
Timeline | Medical history and past interventions | |
---|---|---|
No family history of skin cancer
1999: total gastrectomy for gastric adenocarcinoma |
||
Diagnostic testing and interventions | ||
Past Interventions
2013 – 2017 |
2000: Patient reports onset of nodular skin lesion
2013: Incisional biopsy: BCC CT scan (23-Jan-2013): high local burden of disease (5.0cm AP diameter), with destructive osteo-muscular infiltration - vismodegib 150mg daily from Feb to Nov-2013 2014: relapse of nodular skin lesion Excision biopsy (Feb-2014): SCC Wide surgical excision (22-May-2014): not radical Adjuvant chemotherapy: - cisplatinum/fluorouracil for 3 cycles, Aug – Sep-2014 - radio-chemotherapy with gemcitabine Dec-2014 – Jan-2015 - cisplatinum/docetaxel Aug-2016 – Nov-2016 - gemcitabine monotherapy for 8 cycles Dec-2016 – Jul-2017 |
|
31-Jan-2018 | Baseline assessment | Immunohistochemistry: low/no PD-L1 expression
CT scan (31-Jan-2018): 6.2cm AP diameter |
19-Apr-2018 | Initiation of therapy | - cetuximab initial single dose of 400mg/m2, then 250mg/m2 weekly |
6 weeks | Reassessment | CT scan (28-May-2018): 7.2cm AP diameter
- cetuximab 250mg/m2 every two weeks |
12 weeks | Final outcome | CT scan (12-July-2018): 7.0cm AP diameter
- cetuximab 250mg/m2 every two weeks |
AP, anterior-posterior; BCC, basal cell carcinoma; CT, computerized tomography; SCC, squamous cell carcinoma; PD-L1, programmed cell death ligand-1.